Stay updated on Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial

Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical-trial record for a Phase 2 study of psilocybin for body dysmorphic disorder is displayed, including its eligibility criteria, treatment plan, primary outcome measure, investigators, and study documents.
    Difference
    39%
    Check dated 2026-11-08T12:18:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:33:25.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-25T12:59:38.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site's footer revision changed from v3.7.1 to v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:58:52.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1; no study record content is shown.
    Difference
    0.2%
    Check dated 2026-10-11T14:34:01.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, blocking access to the usual study details. This indicates an access issue rather than content changes.
    Difference
    16%
    Check dated 2026-09-20T20:11:55.000Z thumbnail image

Stay in the know with updates to Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page.